The first around the world to use all-trans retinoic acid to induce differentiation in the treatment of acute promyelocyticleukemia; 8 years later, the first to confirm internationally that the application of arsenic trioxide can specifically induce the apoptosis of acute promyelocytic leukemia, making a breakthrough in the treatment of recurrent leukemi